Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease

Parkinson's disease (PD) is the second most common neurodegenerative disorder. Despite intense investigations, no effective therapy is available to stop its onset or halt its progression. The present study evaluates the ability of peptide corresponding to the NF-κB essential modifier-binding do...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ghosh, Anamitra, Roy, Avik, Liu, Xiaojuan, Kordower, Jeffrey H., Mufson, Elliott J., Hartley, Dean M., Ghosh, Sankar, Mosley, R. Lee, Gendelman, Howard E., Pahan, Kalipada
Format: Artigo
Langue:Inglês
Publié: National Academy of Sciences 2007
Sujets:
Biological Sciences
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2141849/
https://ncbi.nlm.nih.gov/pubmed/18000063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0704908104
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires